Client
Molecular Vision Limited, London, United Kingdom
Developing BioLED™, a miniaturised, low-cost, easy-to-use, disposable, lab-quality, point-of-care diagnostic test that can simultaneously test for multiple disease markers using numerous single amplification methods within the same device.
Mandate
Raise private round from financial or corporate investor to advance BioLED™ platform to commercial proof-of-principle.
Investor(s)
Abingdon Health Limited
Transaction
Structured investment transaction resulting in Abingdon Health Ltd. investing to obtain a controlling interest in the Company. Financial terms were not disclosed
Our Role
Acted as financial advisor to the Board of Directors and management
- Prepared marketing materials and compiled electronic data room
- Designed targeted fund raising campaign approaching a select number of financial and corporate investors.
- Spearheaded negotiation on behalf of the Company with new and existing investors to complete the transaction.
